Quick Takeaways
- Kim Sablich has 2 issuer positions tracked on this page.
- Estimated disclosed ownership value: $3,392,584.
- Recent insider filing activity is available below.
- Info
- Insider Ownership
Insider Trading & Ownership of Kim Sablich
- Location
- Brisbane, CA
- Summary
- The estimated net worth of Kim Sablich is at least $3,392,584 dollars as of 07 Jun 2023. Kim Sablich is the EVP, GM of U.S. of Jazz Pharmaceuticals plc and owns shares of Jazz Pharmaceuticals plc (JAZZ) stock worth about $3.39M.
- Signature
- By: /s/Adam Guttmann, as attorney in fact For: Kimbely Sablich
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Kim Sablich and return when a new Insider Trading filing appears.
This tracks SEC filing changes for this page using existing product update flows.
What Changed
- Largest disclosed position: Jazz Pharmaceuticals plc ($3,392,584).
- Past-year value change for that position: .
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Source Evidence
Filed on Form 4
See Original Filing
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
Ownership of Kim Sablich
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| JAZZ | Jazz Pharmaceuticals plc | EVP, GM of U.S. | $3,392,584 | 05 Jun 2023 | ||
| EIGR | Eiger BioPharmaceuticals, Inc. | Director | 01 Mar 2023 |
Insider Transactions Reported by Kim Sablich:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.